A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects

NCT00460954 · clinicaltrials.gov ↗

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Sinemet® controlled release (Carbidopa/levodopa)

Sponsor

Bristol-Myers Squibb